Evidence map›Paper›PMID 39440933›Full record

ArticleJournal of clinical microbiology2024

Jack W McHugh, David R Bayless, Nischal Ranganath, Ryan W Stevens, Dalton R Kind, Nancy L Wengenack, Aditya S Shah

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Antifungal Susceptibility of ClinicalPathogens (Basel, Switzerland) · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jack W McHughDivision of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0002-7507-232X
David R BaylessDepartment of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Nischal RanganathDivision of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0001-9538-6214
Ryan W StevensDepartment of Pharmacy Services, Mayo Clinic, Rochester, Minnesota, USA.
Dalton R KindDivision of Clinical Microbiology, Department of Laboratory Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Nancy L WengenackDivision of Clinical Microbiology, Department of Laboratory Medicine, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0003-2853-8219
Aditya S ShahDivision of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prevalence of invasive candidiasis caused by non- IMPORTANCE: Our study addresses a significant knowledge gap in the clinical management of this non-

Indexed as

Antifungal AgentsCandidaCandidemiaMicrobial Sensitivity TestsTertiary Care CentersAdolescentAdultAgedAged, 80 and overDrug Resistance, FungalFemaleHumansMaleMiddle AgedRetrospective StudiesRisk FactorsAntifungal Agentsantifungal susceptibility testingCandidafungiimmunocompromised hosts

Identifiers

PMID39440933
PMCPMC11559098

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.